Effect of modest alcohol consumption over 1-2 weeks on the coronary microcirculation of normal subjects

European Journal of Echocardiography

Volumn 11, Issue 8, 2010, Pages 683-689

  Kaul, Sanjiv ^a   Belcik, Todd ^a   Kalvaitis, Saul ^a,b   Jayaweera, Ananda R ^a   Choi, Si Wan ^a,c   Wei, Kevin ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Chungnam National University   (South Korea)

Author keywords

Alcohol; Microcirculation; Myocardial blood flow reserve

Indexed keywords

ALCOHOL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN 2;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD VISCOSITY; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; ERYTHROCYTE DEFORMABILITY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART MUSCLE BLOOD FLOW; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; MALE; MICROCIRCULATION; NORMAL HUMAN; PRIORITY JOURNAL; RED WINE; VODKA;

ADULT; ALCOHOL DRINKING; CORONARY CIRCULATION; DIASTOLE; DIPYRIDAMOLE; ECHOCARDIOGRAPHY; ERYTHROCYTES; ETHANOL; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HEMODYNAMICS; HUMANS; LOGISTIC MODELS; MALE; MICROCIRCULATION; MULTIVARIATE ANALYSIS; MYOCARDIUM; PHOSPHODIESTERASE INHIBITORS; SYSTOLE; VASODILATOR AGENTS;

EID: 77956586966     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jeq042     Document Type: Article

References (36)

1. Shimada K, Watanabe H, Hosoda K, Takeuchi K, Yoshikawa J. Effect of red wine on coronary velocity reserve. Lancet 1999;354:1002.
2. Kiviniemi TO, Saraste A, Toikka JO, Saraste M, Raitakari OT, Parkka JP et al. A moderate dose of red wine, but not de-alcoholized red wine increases coronary flow reserve. Atherosclerosis 2007;195:e176-81.
3. Hozumi T, Sugioka K, Shimada K, Kim SH, Kuo MY, Miyake Y et al. Beneficial effect of short term intake of red wine polyphenols on coronary microcirculation in patients with coronary artery disease. Heart 2006;92:681-2.
4. Jayaweera AR,Wei K, Coggins M, Bin JP, Goodman C, Kaul S. Role of capillaries in determining coronary blood flow reserve: new insights using myocardial contrast echocardiography. Am J Physiol 1999;277:H2363-72.
5. Pries AR, Secomb TW, Gessner T, Sperandio MB, Gross JF, Gaehtgens P. Resistance to blood flow in microvessels in vivo. Circ Res 1994;75:904-15.
6. Pries AR, Secomb TW, Gaehtgens P, Gross JF. Blood flow in microvascular networks: experiments and simulations. Circ Res 1990;67:826-34.
7. Rim S-J, Leong-Poi H, Lindner JR, Wei K, Fisher NG, Kaul S. The decrease in coronary blood flow reserve during hyperlipidemia is secondary to an increase in blood viscosity. Circulation 2001;104:2704-9.
8. Jensen T, Retterstol LJ, Sandset PM, Godal HC, Skjonsberg OH. A daily glass of red wine induces a prolonged reduction in plasma viscosity: a randomized controlled trial. Blood Coagul Fibrinolysis 2006;17:471-6.
9. Bin JP, Doctor A, Lindner JR, Leong-Poi H, Fisher NG, Le ED et al. Effects of nitroglycerin on erythrocyte rheology and oxygen unloading: novel role of S-nitrosohemoglobin in relieving myocardial ischemia. Circulation 2006;113: 2502-8.
10. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473-83.
11. Wei K, Ragosta M, Thorpe J, Moos S, Kaul S. Noninvasive measurement of coronary blood flow reserve using myocardial contrast echocardiography. Circulation 2001;103:2560-5.
12. Le DE, Jayaweera AR, Wei K, Coggins MP, Lindner JR, Kaul S. Changes in myocardial blood volume over a wide range of coronary driving pressures: role of capillaries beyond the autoregulatory range. Heart 2004;90:1199-205.
13. Hardeman MR, Goedhart PT, Schut NH. Laser assisted Optical Rotational Cell Analyser (L.O.R.C.A.). Red blood cell deformability: elongation index versus cell transit time. Clin Hemorheol 1994;14:619-30.
14. Oonishi T, Sakashita K. Ethanol improves decreased filterability of human red blood cells through modulation of intracellular pathways. Alcohol Clin Exp Results 2000;24:352-6.
15. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329:1829-34.
16. Suh I, Shaten BJ, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med 1992;116:881-7.
17. Kelbaek H, Heslet L, Skagen K, Christensen NJ, Godtfredsen J, Munck O. Hemodynamic effects of alcohol at rest and during upright exercise in coronary artery disease. Am J Cardiol 1988;61:61-4.
18. Rosito GA, Fuchs FD, Duncan BB. Dose-dependent biphasic effect of ethanol on 24-h blood pressure in normotensive subjects. Am J Hypertens 1999;12:236-40.
19. Corder R. Endothelin-1 synthesis reduced by red wine. Nature 2001;414:863-4.
20. Davda RK, Chandler LJ, Crews FT, Guzman NJ. Ethanol enhances the endothelial nitric oxide synthase response to agonists. Hypertension 1993;21:939-43.
21. Diebolt M, Bucher B, Andriantsitohaina R. Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension 2001;38:159-65.
22. Fitzpatrick DF, Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 1993;265:H774-8.
23. Kaul S, Jayaweera AR. Determinants of microvascular flow. Eur Heart J 2006;27: 2272-4.
24. Kaul S, Jayaweera AR. Myocardial capillaries and coronary flow reserve. J Am Coll Cardiol 2008;52:1399-401.
25. Hamazaki T, Shishido H. Increase in blood viscosity due to alcohol drinking. Thromb Res 1983;30:587-94.
26. Nagai Y, Isida K, Hirroka M, Nishimaru K. Effect of ethanol on hemorheology in patients with ischemic cerebrovascular disease and elderly healthy men. Clin Hemorhol Microcirc 2001;25:135-44.
27. Chi LM, Wu WG, Sung KLP, Chien S. Biophysical correlates of lysophosphatidylcholine- and ethanol-mediated shape transformation and hemolysis of human erythrocytes: Membrane viscoelasticity and NMR measurement. Biochem Biophys Acta 1990;1027:163-71.
28. McLawhon RW, Marikovsky Y, Thomas NJ,Weinstein RS. Ethanol-induced alterations in human erythrocyte shape and surface property: Modulatory role of prostaglandin E. J Membr Biol 1987;99:73-8.
29. Kelbaek H, Floistrup S, Gjorup T, Christensen NJ, Hartling OJ, Godtfredsen J. Central and peripheral haemodynamic changes after alcohol ingestion. Alcohol 1988;23:211-6.
30. Rendig SV, Symons JD, Longhurst JC, Amsterdam EA. Effects of red wine, alcohol, and quercetin on coronary resistance and conductance arteries. J Cardiovasc Pharmacol 2001;38:219-27.
31. Pikaar NA, Wedel M. van der Beek EJ, van Dokkum W, Kempen HJ, Kluft C. et al. Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metab Clin Exp 1987;36:538-43.
32. Bhat KPL, Kosmeder JW 2nd, Pezzuto JM. Biological effects of resveratrol. Antioxid Redox Signal 2001;3:1041-64.
33. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993;341:1103-4.
34. Dimmitt SB, Rakie V, Puddy IB, Baker R, Oostryck R, Adams MJ et al. The effect of alcohol on coagulation and fibrinolytic factors: a controlled trial. Blood Coagul Fibrinolysis 1998;9:39-45.
35. Szmitko PE, Verma S. Antiatherogenic potential of red wine: clinician update. Am J Physiol 2005;288:H2023-30.
36. Imamura G, Bertelli AA, Bertelli A, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Am J Physiol 2002;282:H1996-2003.